NeoGenomics reports Q4 adjusted EPS 4c, consensus 3c

Reports Q4 revenue $172M, consensus $173.4M. “Our business continued to perform well throughout 2024 and we have now achieved nine consecutive quarters of double digit revenue growth and improved adjusted EBITDA over 1,000% for the year,” said Chris Smith, CEO of NeoGenomics (NEO). “Thanks to the strong execution of our Neo teammates and robust customer demand, we continued to grow all modalities above market, including NGS which grew 34% in 2024.”